Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma

被引：0
作者：
Beinfeld, Molly [1 ]
Lee, Sei [2 ]
McQueen, Brett [3 ]
Fluetsch, Noemi [1 ]
Pearson, Steven [1 ]
Ollendorf, Daniel A. [4 ]
机构：
[1] Inst Clin & Econ Review, Boston, MA 02109 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80309 USA
[4] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
来源：
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY | 2020年 / 27卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1315 / 1320
页数：6
相关论文
共 50 条
  • [41] Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?
    Saifi, Omran
    Kharfan-Dabaja, Mohamed A.
    Zeidan, Youssef H.
    Peterson, Jennifer
    Rule, William G.
    Lester, Scott C.
    Hoppe, Bradford S.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2020, 7 (01) : 13 - 20
  • [42] Targeting B-cell maturation antigen for treatment and monitoring of relapsed/refractory multiple myeloma patients: a comprehensive review
    Yashar, David
    Regidor, Bernard
    Goldwater, Marissa-Skye
    Bujarski, Sean
    Del Dosso, Ashley
    Berenson, James R.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [43] B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myeloma
    Shrestha, Asis
    Alzubi, Marah
    Alrawabdeh, Jawad
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    Al Hadidi, Samer
    EJHAEM, 2024, 5 (03): : 554 - 559
  • [44] Idecabtagene vicleucel (ide-cel) CAR T-cell therapy for relapsed and refractory multiple myeloma
    Anderson, Larry D., Jr.
    FUTURE ONCOLOGY, 2021, 18 (03) : 277 - 289
  • [45] A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
    Chen, Dongjian
    Zhu, Yu
    Chen, Zhi
    Jiang, Songfu
    He, Haiyan
    Qiang, Wanting
    Xiang, Fang
    Sun, Xuedong
    Du, Juan
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3747 - 3756
  • [46] Salvage Radiotherapy in Relapsed/ Refractory Large B-Cell Lymphoma After CAR T-Cell Therapy Failure
    Ababneh, Hazim
    Ng, Andrea
    Frigault, Matthew
    Abramson, Jeremy
    Johnson, Patrick
    Jacobson, Caron
    Patel, Chirayu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S414 - S414
  • [47] Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
    Chong, Elise A.
    Penuel, Elicia
    Napier, Ellen B.
    Lundberg, Rachel K.
    Budde, Lihua E.
    Shadman, Mazyar
    Matasar, Matthew J.
    Bartlett, Nancy L.
    Flinn, Ian W.
    Bosch, Francesc
    Fay, Keith
    Goy, Andre
    Kumar, Anita
    Nastoupil, Loretta J.
    Wei, Michael C.
    Wu, Mei
    Yin, Shen
    Fraietta, Joseph A.
    Chong, Emeline R.
    Schuster, Stephen J.
    BLOOD ADVANCES, 2025, 9 (04) : 696 - 703
  • [48] Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy
    Ababneh, Hazim S.
    Ng, Andrea K.
    Frigault, Matthew J.
    Abramson, Jeremy S.
    Johnson, Patrick Connor
    Jacobson, Caron A.
    Patel, C. G.
    HAEMATOLOGICA, 2023, 108 (11) : 2972 - 2981
  • [49] Ciltacabtagene autoleucel CAR-T therapy targeting B-cell maturation antigen (BCMA) Treatment of multiple myeloma
    Lee, Sarah
    Cowan, Andrew J.
    DRUGS OF THE FUTURE, 2022, 47 (04) : 233 - 238
  • [50] TARGETING B-CELL MATURATION ANTIGEN (BCMA) WITH GSK2857916 ANTIBODY-DRUG CONJUGATE PROVIDES DURABLE RESPONSES IN PATIENTS (PTS) WITH HEAVILY-PRETREATED RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PRELIMINARY RESULTS FROM STUDY BMA117159
    Popat, R.
    Trudel, S.
    Lendvai, N.
    Voorhees, P.
    Reeves, B.
    Libby, E.
    Richardson, P.
    Anderson, L., Jr.
    Sutherland, H.
    Yong, K.
    Hoos, A.
    Gorczyca, M.
    Lahiri, S.
    He, Z.
    Jewell, R.
    Opalinska, J.
    Cohen, A.
    HAEMATOLOGICA, 2018, 103 : 30 - 30
12345